Does Dr. THOMAS HIGGINS have financial conflicts of interest?

Dr. THOMAS HIGGINS (MD) has received a total of $311,954 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $255,543 in personal promotional payouts (consulting, meals, travel) and $56,412 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. THOMAS HIGGINS?

According to CMS Open Payments data, Dr. THOMAS HIGGINS received funding from REGENERON HEALTHCARE SOLUTIONS ($132,739), GENZYME CORPORATION ($69,212), and NEURENT MEDICAL LIMITED ($56,412).

Does Dr. THOMAS HIGGINS receive research grants or speaking fees?

Dr. THOMAS HIGGINS has received $255,543 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $56,412 in clinical research grants.

DR. THOMAS HIGGINS

MDReal-Time Hydrated

Specialty: Otolaryngology

Practice Location: LOUISVILLE, KY 40205

NPI Number: 1750543237

LIFETIME INDUSTRY VALUE

$311,954

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. HIGGINS is a verified Otolaryngology practitioner based in LOUISVILLE, KY.

Between 2021 and 2024, Dr. HIGGINS had an overall industry promotional and research financial footprint of $311,954 as recorded in the federal CMS Open Payments database.

$255,543 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$56,412 was allocated to sponsored clinical trials and medical research activities.

Dr. HIGGINS's primary funding source is REGENERON HEALTHCARE SOLUTIONS, which accounts for $132,739 (representing 42.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

REGENERON HEALTHCARE SOLUTIONS

Rank 1

$132,739

42.6%

GENZYME CORPORATION

Rank 2

$69,212

22.2%

NEURENT MEDICAL LIMITED

Rank 3

$56,412

18.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.